Psilocybin Microdosing on Cognition, Mood and Quality of Life

NCT07449351 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI

Interventions

DRUG: Psliocybin
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]